Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
Palliative & Supportive Care|June 23, 2009
Challenges of illness in metastatic breast cancer: a low-income African American perspectiveMargaret Quinn Rosenzweig, Theresa Wiehagen, Adam Brufsky, et al.
International Journal of Women'S Health|August 8, 2012
Patient preferences for chemotherapies used in breast cancerKathleen Beusterien, Jessica Grinspan, Thomas Tencer, et al.
Cancers|January 11, 2022
Machine Learning to Discern Interactive Clusters of Risk Factors for Late Recurrence of Metastatic Breast CancerJuan Luis Gomez Marti, Adam Brufsky, Alan Wells, et al.
Cancers|April 14, 2025
Deep Learning: A Heuristic Three-Stage Mechanism for Grid Searches to Optimize the Future Risk Prediction of Breast Cancer Metastasis Using EHR-Based Clinical DataXia Jiang, Yijun Zhou, Chuhan Xu, et al.
Cancer Informatics|February 22, 2014
A new method for predicting patient survivorship using efficient bayesian network learningXia Jiang, Diyang Xue, Adam Brufsky, et al.
Breast Cancer Research : BCR|November 22, 2018
Statin drugs to reduce breast cancer recurrence and mortalityColin H Beckwitt, Adam Brufsky, Zoltán N Oltvai, et al.
Protein & Cell|February 15, 2016
RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genesJulia Foldi, Yingli Shang, Baohong Zhao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesMamatha Chivukula, Rohit Bhargava, Adam Brufsky, et al.
Targeted Oncology|August 2, 2021
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical PracticeAdam Brufsky, Xianchen Liu, Benjamin Li, et al.
Breast (Edinburgh, Scotland)|March 26, 2025
Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2- metastatic breast cancer: A Flatiron Health database analysisRachel M Layman, Xianchen Liu, Benjamin Li, et al.
Pageof 21